Issues related to patient access to home medical equipment and related reimbursement.
2026 · 1st Quarter (Jan 1 - Mar 31)
ACCENDRA HEALTH INC.
Filed by ACCENDRA HEALTH INC..
Open official filingSource-reported fields
Filing overview
- Type
- 1st Quarter - Report
- Posted
- Apr 15, 2026
- Income
- Not reported
- Expenses
- $280,000.00
- Registrant
- ACCENDRA HEALTH INC.
- Client
- ACCENDRA HEALTH INC.
- Filing UUID
- 26494419-d030-4db1-92da-4e47dda1aadb
- Termination date
- Not reported
Expense method: A
Literal source text
Lobbying issues and bill citations
Issues related to access to home medical equipment and related reimbursement (i.e., the "Diabetes Interventions Addressing Barriers to Enrollment, Technology, and Education Services [DIABETES] Act" (S. 4307) and the "DMEPOS Relief Act of 2025" [H.R. 2005, S. 2951]; and competitive bidding, the "Supplemental Oxygen Access Reform [SOAR] Act of 2025" [H.R. 2902, S. 1406]); promoting electronic prescribing platforms; and diabetes management and related durable medical equipment reimbursement channels.
Literal federal measure citations: S. 4307, H.R. 2005, S. 2951, H.R. 2902, S. 1406
FY 2027 Appropriations.
CHAMPVA medical supply reimbursement.
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.